» Articles » PMID: 34655326

The Effects of SmartCare on Neuro-oncology Family Caregivers' Distress: a Randomized Controlled Trial

Overview
Specialties Critical Care
Oncology
Date 2021 Oct 16
PMID 34655326
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Patients with primary malignant brain tumors have high symptom burden and commonly rely on family caregivers for practical and emotional support. This can lead to negative mental and physical consequences for caregivers. We investigated effectiveness of an 8-week nurse-led online needs-based support program (SmartCare) with and without online self-guided cognitive behavioral therapy (CBT) for depression compared to enhanced care as usual (ECAU) on depressive symptoms, caregiving-specific distress, anxiety, mastery, and burden.

Methods: Family caregivers scoring ≥ 6 on a depressive symptoms inventory were randomized to three groups: ECAU plus self-guided CBT and SmartCare; ECAU plus SmartCare; ECAU only. Primary outcomes (depressive symptoms; caregiving-specific distress) and secondary outcomes (anxiety, caregiver mastery, and caregiver burden) were assessed online. Intention to treat (ITT) and per protocol (PP) analyses of covariance corrected for baseline scores were performed for outcomes at 4 months.

Results: In total, 120 family caregivers participated. Accrual and CBT engagement were lower than expected, therefore intervention groups were combined (n = 80) and compared to ECAU (n = 40). For depressive symptoms, no statistically significant group differences were found. Caregiving-specific distress decreased in the intervention group compared with ECAU (ITT: p = 0.01, partial ɳ = 0.08; PP: p = 0.02, partial ɳ = 0.08). A trend towards improvement in mastery for the intervention group compared with ECAU was identified (ITT: p = 0.08, partial ɳ = 0.04; PP: p = 0.07, partial ɳ = 0.05).

Conclusions: SmartCare, with or without self-guided CBT, reduced caregiving-specific distress with a trend towards improving mastery. SmartCare has the potential to improve the lives of families coping with a brain tumor diagnosis.

Trial Registration Number: NCT02058745; 10 February 2014.

Citing Articles

Reporting standards in randomized controlled trials involving neuro-oncology caregivers: A systematic review report from the RANO-Cares working group.

Boele F, Hertler C, Sherwood P, Cachia D, Dirven L, Young J Neurooncol Pract. 2025; 12(1):19-33.

PMID: 39917763 PMC: 11798602. DOI: 10.1093/nop/npae086.


Symptom management in isocitrate dehydrogenase mutant glioma.

Walbert T, Avila E, Boele F, Hertler C, Lu-Emerson C, van der Meer P Neurooncol Pract. 2025; 12(Suppl 1):i38-i48.

PMID: 39776527 PMC: 11703367. DOI: 10.1093/nop/npae088.


Needs of Patients With Gynecologic Cancer and Their Caregivers for Obtaining mHealth-Supported Self-Management: Focus Group Study.

Campbell G, Kim H, Klinedinst T, Klinger J, Lee Y, Donovan H JMIR Cancer. 2024; 10:e48465.

PMID: 39361371 PMC: 11487211. DOI: 10.2196/48465.


Integrating Family Caregivers Into Cancer Care: Implementation of Evidence-Based Caregiver Protocols Into Gynecologic Oncology Practice.

Thomas T, Campbell G, Tan K, Murray P, Loughlin K, Roberge M JCO Oncol Pract. 2024; :OP2400383.

PMID: 39167743 PMC: 11842612. DOI: 10.1200/OP.24.00383.


The impact of a primary brain tumor diagnosis on caregivers: Insights from the patients' perspective.

Willis K, Reid M, Fox A, Kleva C, Sherwood P, Loughan A Support Care Cancer. 2024; 32(9):595.

PMID: 39160352 PMC: 11333512. DOI: 10.1007/s00520-024-08783-x.


References
1.
Foroushani P, Schneider J, Assareh N . Meta-review of the effectiveness of computerised CBT in treating depression. BMC Psychiatry. 2011; 11:131. PMC: 3180363. DOI: 10.1186/1471-244X-11-131. View

2.
Christensen H, Griffiths K, Farrer L . Adherence in internet interventions for anxiety and depression. J Med Internet Res. 2009; 11(2):e13. PMC: 2762797. DOI: 10.2196/jmir.1194. View

3.
Sherwood P, Cwiklik M, Donovan H . Neuro-oncology family caregiving: review and directions for future research. CNS Oncol. 2015; 5(1):41-8. PMC: 6078154. DOI: 10.2217/cns.15.43. View

4.
IJzerman-Korevaar M, Snijders T, de Graeff A, Teunissen S, de Vos F . Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review. J Neurooncol. 2018; 140(3):485-496. PMC: 6267240. DOI: 10.1007/s11060-018-03015-9. View

5.
Chi N, Demiris G . A systematic review of telehealth tools and interventions to support family caregivers. J Telemed Telecare. 2014; 21(1):37-44. PMC: 4486048. DOI: 10.1177/1357633X14562734. View